Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), ...

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...

Dr. Nicoletta Colombo breaks down KEYNOTE B96 showing Keytruda plus paclitaxel, with or without Avastin, improves survival in platinum-resistant ovarian cancer. The phase 3 KEYNOTE B96 trial showed ...

Healthcare social media content gathered by MedPage Today staff ...

Apollo Athenaa Cancer Conclave 2026 will bring global experts to discuss precision, evidence-based breast cancer care in ...

Body Image and Stigma Experiences among Secondary to Genital Neoplasms, Female Surgery: A Qualitative Study Objective: To explore the lived experiences of body image alterations and stigma in patients ...

India, March 12 -- The Delhi Government is planning to introduce two new specialised medical programmes at major government ...

Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published today ...

Montana Technological University has announced alumna Dr. Hannah (Dysinger) McLaughlin as the keynote speaker for its Spring 2026 commencement ceremonies on May ...

"I dismissed my fear as paranoia. But, deep down, I still felt that something was wrong." ...

As an OB-GYN training to be a complex family planning subspecialist at UC San Diego, I have seen misinformation about ...

Cancer Clinician and Translational Scientist Dr. Daniela Matei will become the next director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center following a national search, Houston Methodist ...